WASHINGTON (dpa-AFX) - Waters Corp. (WAT) and Protea Biosciences Group, Inc. announced a co-marketing agreement enabling customers of Waters SYNAPT G2 & G2-S HDMS systems to take advantage of Protea's LAESI DP-1000. The combination of the technologies enables laboratories to perform fast and direct analyses of biological samples.
Under the agreement, Protea will make the LAESI DP-1000 available to new and existing users of Waters' SYNAPT G2 and SYNAPT G2-S mass spectrometers running under MassLynx control.
Protea's LAESI DP-1000 system uses Laser Ablation Electrospray Ionization technology to help identify biomolecules like metabolites, lipids, peptides, and proteins in native biological samples including tissue, blood, urine, live cells, and colonies.
Copyright RTT News/dpa-AFX
© 2012 AFX News
